Paper Details
- Home
- Paper Details
Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study.
Author: BaranWojciech, FerrisLaura K, HanChenglong, HongH Chih-Ho, JiangJingzhi, LiShu, OttElyssa
Original Abstract of the Article :
<b>Objectives:</b> Guselkumab, an interleukin-23 antagonist, is approved for self-administration with the UltraSafe Plus™ syringe to treat moderate-to-severe plaque-type psoriasis. We evaluated the efficacy, safety, pharmacokinetics, and acceptability of guselkumab administered using a novel ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/09546634.2019.1587145
データ提供:米国国立医学図書館(NLM)
Guselkumab: A Novel Approach to Treating Psoriasis
Psoriasis, a chronic skin condition, can be a frustrating challenge for patients, like a persistent sandstorm that leaves its mark on the skin. This 2019 study investigated the efficacy and safety of guselkumab, an interleukin-23 antagonist, administered using a new patient-controlled injector (One-Press) in patients with moderate-to-severe psoriasis. This research, like a caravan exploring a new route through the desert, aimed to find a more convenient and effective treatment for psoriasis. The study found that guselkumab, delivered via the One-Press injector, was highly effective in reducing psoriasis symptoms, leading to significant improvements in skin clearance and overall quality of life. This discovery is like finding a hidden oasis in the desert of psoriasis, offering relief and hope for a clearer future.
Patient Satisfaction and Usability: A Comfortable Oasis
The study found that the One-Press injector was highly acceptable to patients, with 99% of participants expressing satisfaction or very high satisfaction with the device. This is like finding a comfortable and reliable camel saddle for a long and arduous journey. The researchers also observed that the guselkumab treatment was well-tolerated, with adverse events comparable to those seen in previous studies using a traditional syringe. This is a positive finding, like finding a safe and smooth path through a desert landscape, making the journey more comfortable and less fraught with danger.
A New Era of Psoriasis Treatment
This study highlights the potential of guselkumab, administered via a patient-controlled injector, as a promising new treatment for moderate-to-severe psoriasis. This is like finding a new oasis in the desert of psoriasis treatment, offering hope for a more manageable future. The study's findings suggest that this innovative approach could significantly improve the lives of psoriasis patients, enabling them to live more comfortably and confidently.
Dr.Camel's Conclusion
This study offers a promising new approach to treating psoriasis, making the journey through the desert of this chronic condition more manageable and comfortable for patients. It's like finding a new oasis, providing relief and hope for a brighter future.
Date :
- Date Completed 2020-04-07
- Date Revised 2020-04-08
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.